May 21, 2020 — Two late-breaking clinical trials on trans catheter valves to treat congenital heart disease were presented at the 2020 Society for...
Congenital Heart
This Congenital Heart Disease channel includes news and new technology to diagnose, treat and manage congenital heart disease. This includes transposed vessels, tetralogy of Fallot, pediatric cardiomyopathy, pulmonary heart valves, pulmonary atresia, patent foramen ovale (PFO), atrial septal defect (ASD) and ventricular septal defect (VSD).
-
-
May 4, 2020 – The Society for Cardiovascular Angiography and Interventions (SCAI) has released a position statement on adult congenital cardiac...
-
Karen Ordovas, M.D., MAS, professor of radiology and cardiology at the University of California San Francisco (UCFS) School of...
-
Left, the Melody pulmonary valve was the first transcatheter valve to be approved by the FDA in the United States a decade ago. Right, the Harmony transcatheter valve is in trials and is designed to treat patients with RVOT anomalies who develop severe PR typically when a pervious repair fails. Both valves are used to treat congenital heart defects.
News | Congenital Heart | May 21, 2020
May 21, 2020 — Two late-breaking clinical trials on trans catheter valves to treat congenital heart disease were...
A congenital atrial septal defect closed using a transcatheter occluder, visualized on 3-D TEE ultrasound.
News | Congenital Heart | May 04, 2020
May 4, 2020 – The Society for Cardiovascular Angiography and Interventions (SCAI) has released a position statement on...
Videos | Magnetic Resonance Imaging (MRI) | January 06, 2020
Karen Ordovas, M.D., MAS, professor of radiology and cardiology at the University of California San Francisco (UCFS)...
News | Congenital Heart | October 24, 2019
October 24, 2019 — Investigators at the University of Arizona Steele Children's Research Center are leading a statewide...
News | Congenital Heart | September 20, 2019
September 20, 2019 – Abbott announced approvals in Europe for two of its pediatric devices — the Masters HP 15mm...
News | Heart Failure | September 20, 2019
September 20, 2019 — The new Max and Debra Ernst Heart Center at Beaumont Hospital, Royal Oak, Mich., will open Sept....
News | Hypertension | July 29, 2019
July 29, 2019 — High blood pressure among children is on the rise and a lack of research about how to treat it has...
News | Congenital Heart | July 16, 2019
July 16, 2019 — Elevated blood pressure and cholesterol levels in young adulthood may lead to an increased risk of...
Image courtesy of Flinders University
News | Implantable Cardiac Monitor (ICM) | July 09, 2019
July 9, 2019 — South Australian researchers are developing a tiny fiber-optic sensor, which has the potential to change...
Videos | Virtual and Augmented Reality | June 20, 2019
David M. Axelrod, M.D., clinical associate professor in pediatrics (cardiology) at Stanford School of Medicine,...
Videos | Artificial Intelligence | June 18, 2019
Anthony Chang, M.D., chief artificial intelligence officer, Children’s Hospital of Orange County (CHOC), and founder,...
Technology | Structural Heart Occluders | June 10, 2019
June 10, 2019 – W. L. Gore & Associates (Gore) announced the U.S. Food and Drug Administration’s (FDA’s) premarket...
News | Congenital Heart | June 03, 2019
June 3, 2019 — Researchers at University of California San Diego School of Medicine found higher blood pressure and...
Fragmin (dalteparin sodium) injection is now cleared by the FDA for use in pediatric patients. It was initially approved by the FDA in 1994 for adults and is a type of heparin.
Technology | Antiplatelet and Anticoagulation Therapies | May 17, 2019
May 17, 2019 — The U.S. Food and Drug Administration (FDA) this week approved Fragmin (dalteparin sodium) injection,...
News | Congenital Heart | April 29, 2019
April 29, 2019 — Edwards Lifesciences is recalling the Miller Balloon Atrioseptostomy Catheter and Fogarty Dilation...
